|Videos|August 9, 2022

Factors for Consideration when Choosing an ADT Regimen for mCSPC

Author(s)Jason Hafron, MD

Jason Hafron, MD, revisits the patient profile and discusses factors that inform treatment decision-making in mCSPC.

Episodes in this series

EP. 1 Introduction: A 66-Year-Old-Man with Metastatic Prostate Cancer

EP. 1 Introduction: A 66-Year-Old-Man with Metastatic Prostate Cancer

EP. 2 Available Monotherapies and Combination Therapies in mCSPC

EP. 2 Available Monotherapies and Combination Therapies in mCSPC

EP. 3 Factors for Consideration when Choosing an ADT Regimen for mCSPC

EP. 3 Factors for Consideration when Choosing an ADT Regimen for mCSPC

EP. 4 Unmet Needs and Investigational Therapies in mCSPC

EP. 4 Unmet Needs and Investigational Therapies in mCSPC

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

ByLorelei A. Mucci, ScD, MPH

September 11th 2026

Doublet or triplet? Urologists weighs in on mCSPC options

ByUrology Times staff

September 10th 2026

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 10th 2026

App-based intervention aims to increase PSA screening among Black men

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC